Navigation Links
PAREXEL Introduces Executive Briefing Series on Proven Practices to Assist Emerging and Mid-size Biopharma in Achieving Better Outcomes
Date:12/21/2011

BOSTON, Dec. 21, 2011 /PRNewswire/ -- To help emerging and mid-size biopharmaceutical companies address an increasingly challenging regulatory and commercial environment, PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it is introducing a series of executive briefings with clinical operations and outsourcing leaders worldwide.  During these forums, PAREXEL will discuss how a spectrum of proven operating practices and relationship models can significantly reduce timelines and costs and streamline protocols and programs.

Through these educational briefings, designed for emerging and mid-size biopharmaceutical companies, PAREXEL senior project leaders and teams will discuss customized solutions that can assist companies in achieving their short- and long-term development and commercialization milestones. The teams will address key issues that may impact critical areas for emerging and mid-sized biopharmaceutical companies, including:

  • Optimizing patient recruitment strategy
  • Meeting "first patient in" timelines
  • Accessing real-time data
  • Achieving database lock timelines
  • Accelerating the speed of site recruitment
  • Implementing risk management and contingency planning approaches
  • "Deep collaboration with emerging and mid-size biopharmaceutical companies has been part of our DNA for nearly 30 years. We are committed to continuing to work with these clients to help them navigate the next stages of their businesses in the 'niche-buster' era, and in a challenging regulatory and commercial environment," said Mark A. Goldberg, M.D., Chief Operating Officer, PAREXEL. "Through a flexible and innovative approach, we create solutions that are the 'right fit' for every client. We're looking forward to bringing th
    '/>"/>

    SOURCE PAREXEL International Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related biology technology :

    1. PAREXEL Closes the Acquisition of ClinPhone
    2. PAREXEL Data Indicate U.S. Marketing Applications for New Molecular Entities Bounce Back
    3. PAREXEL International To Present at Thomas Weisel Partners Healthcare Conference
    4. PAREXEL International Updates Financial Guidance in Conjunction With the Acquisition of ClinPhone Plc and Other Factors
    5. PAREXEL International to Present at William Blair Small-Cap Growth Stock Conference
    6. PAREXEL Consulting Quantifies Speed to Market: First-Cycle Approval for NME Produces $640 Million in Incremental Revenue on Average
    7. PAREXEL Corporate Vice President Dr. Alberto Grignolo Receives Lifetime Achievement Award From Good Clinical Practice Journal
    8. PAREXEL Partners with Glenmark to Win the Good Clinical Practice Journal Award for Most Innovative Patient Recruitment Strategy
    9. PAREXEL International to Present at Oppenheimer 19th Annual Healthcare Conference
    10. PAREXEL Expert to Address Key Aspects of Conducting Clinical Trials in China at 7th Annual Partnerships in Clinical Trials Congress
    11. PAREXEL Expands Pioneering Asian Ethnobridging Expertise
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/24/2014)... July 24, 2014  Asterias Biotherapeutics, Inc. (OTCBB: ... field of regenerative medicine, announced today that it ... to investors on Tuesday, July 29, 2014, at ... will include an overview of Asterias, business strategy ... visit http://www.ustream.tv/channel/asterias-biotherapeutics at least 15 minutes ...
    (Date:7/24/2014)... yet to materialise. Yet, scientists are making progress ... faster. One such approach relies on quantum dotsa ... an electric field. A new study demonstrates that ... dots (TQDs) with electrical impulses can help better ... TQDs be used as quantum information units, which ...
    (Date:7/24/2014)... Research and Markets has announced the addition ... Market 2014-2018" report to their offering. ... the study of the gene and its functions and ... of proteomes or sets of proteins by using molecular ... mapping of genes and DNA sequencing to understand the ...
    (Date:7/24/2014)... July 24, 2014 Three companies from ... in Livestrong’s Big C Competition. Out of 700 competition ... headed to the semi-final round. In this round twenty ... accelerator program, complete with mentoring from thought-leaders and medical ... part of the angelMD commitment to the Livestrong vision ...
    Breaking Biology Technology:Asterias Biotherapeutics Announces Live Investor Webcast 2Asterias Biotherapeutics Announces Live Investor Webcast 3Asterias Biotherapeutics Announces Live Investor Webcast 4Global Genomics and Proteomics Analytical Instruments Market 2014-2018: Key Vendors are Agilent, Bio-Rad , F. Hoffmann, La Roche, Illumina, PerkinElmer and Thermo Fisher Scientific 23 angelMD Startups Make Livestrong Big C Semi-finals 2
    ... EMERYVILLE, Calif., Aug. 3 NovaBay Pharmaceuticals, Inc. ... J. Wu has joined the company as senior vice ... than 30 years of highly successful experience in the ... business development, licensing, international marketing, project management, clinical development, ...
    ... , BOTHELL, WA and VANCOUVER, Aug. 3 /PRNewswire-FirstCall/ - OncoGenex ... Company will announce second quarter financial results on Thursday, August ... webcast at 4:30 p.m. EDT that afternoon to discuss quarterly ... Relations page of the OncoGenex Web site at www.oncogenex.com ...
    ... COUNTY, Calif., Aug. 2 Beckman Coulter, Inc. (NYSE: ... products that simplify, automate and innovate complex biomedical testing, announced ... business. This acquisition, first announced in February, extends Beckman ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO ...
    Cached Biology Technology:NovaBay(R) Pharmaceuticals Names Roy J. Wu as Senior Vice President for Business Development 2NovaBay(R) Pharmaceuticals Names Roy J. Wu as Senior Vice President for Business Development 3Beckman Coulter Completes Acquisition of Olympus' Lab-Based Diagnostics Business 2
    (Date:7/25/2014)... the age girls reach puberty is influenced by ,imprinted genes,a ... contributes the gene. This is the first evidence that ... and details of this study were published today in the ... known as menarche, is a marker for the timing of ... of menses varies between girls, is an inherited trait, and ...
    (Date:7/25/2014)... CORAL SPRINGS, Florida , July 25, 2014 /PRNewswire/ ... influential as more consumers are turning to digital technology ... NXT-ID, Inc. (OTCBB: NXTD), Google Inc. (NASDAQ: ... Visa Inc. (NYSE: V ), Apple Inc. ... FTNT) NXT-ID, Inc., (OTCQB: NXTD) a biometric ...
    (Date:7/24/2014)... July 24, 2014 /PRNewswire-iReach/ -- The Geneva Healthcare Suite, ... devices, has cut emergency room wait times by an ... (UCSD) Medical Center, according to a recent study published ... Departments are using the suite to access data from ... defibrillators. "Using Geneva,s technology platform we have ...
    Breaking Biology News(10 mins):Could age of first period influence development of diseases in older women? 2Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 2Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 3Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 4Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 5Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 6UC San Diego Medical Center Cuts Average ER Wait Time by 92 Minutes using the Geneva Healthcare Suite 2UC San Diego Medical Center Cuts Average ER Wait Time by 92 Minutes using the Geneva Healthcare Suite 3
    ... its introduction fifty or so years ago, thermography has been ... in horses. The method is fast and safe and ... surface emits infrared radiation that can be detected by an ... The camera produces a coloured image that shows the ...
    ... received a $12 million grant from the National Institutes ... research on aphasia, a devastating language disorder that essentially ... U.S. alone, more than one million people suffer from ... will direct the new Center for the Neurobiology of ...
    ... dioxide in the Earth,s atmosphere created by the widespread burning ... climate change, and researchers the world over are looking for ... footprint. Now, researchers at the University of Georgia ... in the atmosphere into useful industrial products. Their discovery may ...
    Cached Biology News:Blowing in the wind: How accurate is thermography of horses' legs? 2$12 million for a center for research on aphasia 2$12 million for a center for research on aphasia 3UGA discovery may allow scientists to make fuel from CO2 in the atmosphere 2
    ... iLink makes it easy to supply microplates, ... Developed with operator convenience in mind, iLink ... ease of use. The iLink software is ... assays or sub-assays, that can be copied ...
    ... digital microscope and camera system that does ... adjustment or software installation. Built on Nikon's ... simplicity and advanced technology for users of ... of a macro image and a micro ...
    ... Drive for individual and parallel agitation control ... of DASGIP vessels, featuring range of stirring ... to 16 overhead drives can be operated ... fedbatch-pro® and cellferm-pro® for microbiology and cell ...
    This kit is designed to select cells labeled with biotinylated antibodies. Kit includes reagents for labeling 3 x 10 9 cells and EasySep magnet....
    Biology Products: